Evidence brief · printable

Age-Related Macular Degeneration evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Age-Related Macular Degeneration

Print or save as PDF Fits on one A4 or Letter page.

Age-Related Macular Degeneration: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/age-related-macular-degeneration.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Ranibizumab 7 trials
  • AGN211745 6 trials
  • Bevacizumab 4 trials
  • Aflibercept 3 trials
  • SCT520FF 3 trials
  • Bevasiranib 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Education, coaching and self-management 6 trials · 3 completed · 1 with results
  • Acupuncture and related techniques 2 trials · 1 completed · 1 with results
  • Light and laser therapy (photobiomodulation) 14 trials · 6 completed · 0 with results
  • Omega-3 fatty acids and fish oil 4 trials · 3 completed · 0 with results
  • Biofeedback 4 trials · 2 completed · 0 with results
  • Curcumin and other polyphenols 3 trials · 2 completed · 0 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular… NCT07185841
  • Extension Study for the Port Delivery System With Ranibizumab (Portal) NCT03683251
  • Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity,… NCT07007065
  • Strategies for Improving Linkage-to-Care After Eye Disease Screening NCT06943599
  • Effect of Video Viewing on Intravitreal Injection Experience NCT07002372
  • Expressive Arts-based Intervention for Adults With Age-related Visual Impairment NCT05675150

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 30 trials of supplements and nutraceuticals found, none measured mood, anxiety and wellbeing 6 trials of other approaches did
  • Among 16 trials of oxygen, light, temperature and manual therapies found, none measured mood, anxiety and wellbeing 6 trials of other approaches did
  • Among 16 trials of oxygen, light, temperature and manual therapies found, none measured weight and metabolic markers 4 trials of other approaches did
  • Supplements and nutraceuticals: feasibility, adherence and safety 4 trials, no results posted yet
  • Supplements and nutraceuticals: clinical events, survival and healthcare use 3 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (87 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.